A detailed history of Raab & Moskowitz Asset Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Raab & Moskowitz Asset Management LLC holds 1,514 shares of LLY stock, worth $1.2 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
1,514
Previous 1,451 4.34%
Holding current value
$1.2 Million
Previous $1.31 Million 2.13%
% of portfolio
0.34%
Previous 0.36%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$772.14 - $960.02 $48,644 - $60,481
63 Added 4.34%
1,514 $1.34 Million
Q2 2024

Aug 15, 2024

BUY
$724.87 - $909.04 $30,444 - $38,179
42 Added 2.98%
1,451 $1.31 Million
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $21,911 - $29,314
37 Added 2.7%
1,409 $1.1 Million
Q4 2023

Feb 02, 2024

SELL
$525.19 - $619.13 $22,583 - $26,622
-43 Reduced 3.04%
1,372 $799,000
Q2 2023

Aug 07, 2023

BUY
$350.74 - $468.98 $7,716 - $10,317
22 Added 1.58%
1,415 $663,000
Q4 2022

Jan 27, 2023

SELL
$321.55 - $374.67 $21,543 - $25,102
-67 Reduced 4.59%
1,393 $0
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $7,412 - $8,446
-25 Reduced 1.68%
1,460 $472,000
Q1 2022

May 10, 2022

BUY
$234.69 - $291.66 $38,019 - $47,248
162 Added 12.24%
1,485 $425,000
Q4 2020

Feb 12, 2021

BUY
$130.46 - $172.63 $172,598 - $228,389
1,323 New
1,323 $223,000
Q3 2020

Nov 13, 2020

SELL
$146.22 - $169.13 $195,496 - $226,126
-1,337 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$136.42 - $164.18 $182,393 - $219,508
1,337 New
1,337 $219,000
Q1 2020

May 14, 2020

SELL
$119.05 - $147.35 $159,169 - $197,006
-1,337 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$106.92 - $132.43 $142,952 - $177,058
1,337 New
1,337 $175,000
Q4 2018

Feb 04, 2019

SELL
$105.9 - $118.64 $142,223 - $159,333
-1,343 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$85.86 - $107.31 $115,309 - $144,117
1,343 New
1,343 $144,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Raab & Moskowitz Asset Management LLC Portfolio

Follow Raab & Moskowitz Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raab & Moskowitz Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Raab & Moskowitz Asset Management LLC with notifications on news.